022sek
-0,9 %
Date:2025-06-30Time:18:00:00Latest report:Q1-2025List:First NorthTicker:SIMRIS B
Market Cap:139 msekEnterprise Value:136 msekNet Sales:2,53 msekEarnings:-31,5 msekEmployees:0ISIN:SE0008091664
Ratios
10-year key figure history for Simris Alg turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Simris Alg with index and moving average MA50 and MA200.
Stockprice:0,22
MA50:0,12
MA200:0,10
Price/MA200:116,8 %
RSI (14):75,0
Price/MA50:87,8 %
Description
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.